User profiles for Luc Cabel
 | Luc CabelCurie Verified email at curie.fr Cited by 2664 |
Circulating tumor cells: clinical validity and utility
L Cabel, C Proudhon, H Gortais, D Loirat… - International journal of …, 2017 - Springer
Circulating tumor cells (CTCs) are rare tumor cells and have been investigated as diagnostic,
prognostic and predictive biomarkers in many types of cancer. Although CTCs are not …
prognostic and predictive biomarkers in many types of cancer. Although CTCs are not …
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
L Cabel, C Proudhon, E Romano, N Girard… - Nature reviews Clinical …, 2018 - nature.com
Considerable interest surrounds the use of immune-checkpoint inhibitors in patients with
solid tumours following the demonstration of the impressive clinical efficacy of anti-programmed …
solid tumours following the demonstration of the impressive clinical efficacy of anti-programmed …
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
…, L de Mattos-Arruda, M Ignatiadis, L Cabel… - Critical reviews in …, 2019 - Elsevier
Background The heterogeneity of metastatic breast cancer (MBC) necessitates novel
biomarkers allowing stratification of patients for treatment selection and drug development. We …
biomarkers allowing stratification of patients for treatment selection and drug development. We …
Prognostic impact of residual HPV ctDNA detection after chemoradiotherapy for anal squamous cell carcinoma
Purpose: Chemoradiotherapy (CRT) is the current standard of care for patients diagnosed
with locally advanced anal squamous cell carcinoma (ASCC), but some patients develop local …
with locally advanced anal squamous cell carcinoma (ASCC), but some patients develop local …
Clinical utility of circulating tumor cells: An update
The prognostic role of circulating tumor cells (CTCs) has been clearly demonstrated in many
types of cancer. However, their roles in diagnostic and treatment strategies remain to be …
types of cancer. However, their roles in diagnostic and treatment strategies remain to be …
Efficacy of circulating tumor cell count–driven vs clinician-driven first-line therapy choice in hormone receptor–positive, ERBB2-negative metastatic breast cancer: The …
…, G Emile, JM Ferrero, D Loirat, S Frank, L Cabel… - JAMA …, 2021 - jamanetwork.com
Importance The choice between chemotherapy and endocrine therapy as first-line treatment
for hormone receptor–positive, ERBB2 (also known as HER2)-negative metastatic breast …
for hormone receptor–positive, ERBB2 (also known as HER2)-negative metastatic breast …
[HTML][HTML] Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy
Introduction Immune checkpoint inhibitors (ICIs) have proved to be an effective treatment for
up to 40% of muscle-invasive bladder cancer (MIBC), but there is still a need for better …
up to 40% of muscle-invasive bladder cancer (MIBC), but there is still a need for better …
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Background Cancer patients have been reported to be at higher risk of COVID-19 complications
and deaths. We report the characteristics and outcome of patients diagnosed with …
and deaths. We report the characteristics and outcome of patients diagnosed with …
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: The randomised CirCe01 trial
Background CirCe01 trial aimed to assess the clinical utility of circulating tumour cell (CTC)-based
monitoring in metastatic breast cancer (MBC) patients beyond the third line of …
monitoring in metastatic breast cancer (MBC) patients beyond the third line of …
[HTML][HTML] HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
Background Chemoradiotherapy (CRT) is the standard of care for patients diagnosed with
locally advanced cervical cancer (LACC), a human papillomavirus (HPV)-related cancer that …
locally advanced cervical cancer (LACC), a human papillomavirus (HPV)-related cancer that …
